Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$772
|
$728B |
13.7x |
33.8x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$164
|
$407B |
4.5x |
12.3x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$189
|
$399B |
6.8x |
15.1x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 415
|
$303B |
6.2x |
12.3x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 260
|
$285B |
3.7x |
9.3x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 92
|
$251B |
4.5x |
10.9x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£103
|
$244B |
4.1x |
12.0x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$80
|
$226B |
3.5x |
8.1x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$295
|
$207B |
6.0x |
11.1x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$183B |
2.9x |
7.5x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$108
|
$152B |
5.3x |
11.8x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$136B |
2.9x |
10.8x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€84
|
$135B |
2.6x |
8.5x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$460
|
$114B |
9.9x |
34.1x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£13
|
$93.4B |
2.2x |
6.3x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4341
|
$75.9B |
2.4x |
9.2x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 7004
|
$73.2B |
8.8x |
17.7x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$149
|
$71.2B |
7.6x |
17.6x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€28
|
$70.8B |
1.3x |
6.2x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€112
|
$65.5B |
2.6x |
9.1x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$54.8B |
3.6x |
14.4x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$543
|
$52.9B |
3.9x |
10.8x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 59
|
$51.4B |
12.2x |
45.4x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1694
|
$44.7B |
7.1x |
25.0x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3598
|
$42.1B |
3.1x |
15.2x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$321
|
$40.5B |
15.4x |
204.9x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€41
|
$40.4B |
1.5x |
9.4x |
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 127
|
$40.4B |
8.2x |
35.5x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 54
|
$33.9B |
1.9x |
6.7x |
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 190
|
$32.5B |
7.2x |
-643.9x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€492
|
$32.1B |
10.0x |
69.7x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 46
|
$28.5B |
2.5x |
12.3x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 36
|
$24.1B |
13.3x |
35.9x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$23.9B |
1.7x |
5.5x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 9
|
$22.9B |
2.3x |
6.5x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 6581
|
$22.8B |
1.4x |
6.2x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$125
|
$22.3B |
2.4x |
7.0x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1449
|
$22.2B |
1.7x |
8.4x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6732
|
$20.5B |
17.8x |
55.0x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$103
|
$19.4B |
46.4x |
-21.0x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€11
|
$19.3B |
2.2x |
9.0x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$19.1B |
N/A |
-73.3x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 89
|
$18.7B |
12.6x |
288.2x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 321
|
$17.8B |
33.7x |
82.2x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 199
|
$16.7B |
10.7x |
31.6x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 141
|
$15.6B |
38.2x |
-4511.9x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€52
|
$15.1B |
5.1x |
13.8x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$15.0B |
3.5x |
15.3x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3521
|
$14.2B |
10.2x |
31.2x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2653
|
$13.5B |
8.9x |
35.1x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1482
|
$12.8B |
3.9x |
15.3x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$132
|
$12.6B |
5.0x |
20.9x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 9
|
$12.3B |
3.0x |
12.1x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1258
|
$12.1B |
3.1x |
11.8x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 24
|
$11.9B |
2.0x |
13.1x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€69
|
$11.7B |
6.1x |
19.2x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$44
|
$11.3B |
5.0x |
14.8x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$11.2B |
2.5x |
12.8x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€152
|
$11.2B |
N/A |
N/A |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 389
|
$11.1B |
40.4x |
-249.0x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 272
|
$11.0B |
3.9x |
10.6x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 975
|
$10.9B |
3.9x |
13.5x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.9B |
1.7x |
5.6x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 45
|
$10.8B |
1.8x |
14.0x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$68
|
$10.8B |
2.4x |
15.6x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1419
|
$10.7B |
3.0x |
8.6x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1931
|
$10.4B |
3.8x |
15.9x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$110
|
$10.4B |
3.6x |
-7.1x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2493
|
$10.4B |
3.3x |
8.2x |
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$57
|
$10.3B |
3.4x |
13.1x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$47
|
$10.1B |
28.1x |
-22.1x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€106
|
$10.1B |
2.4x |
6.7x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$292
|
$10.1B |
3.3x |
6.2x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$113
|
$9.7B |
2.3x |
7.4x |
Blueprint Medicines
|
United States of America |
Drug Development & Therapeutics
|
$129
|
$8.3B |
13.2x |
-79.3x |
Salubris Pharmaceuticals
|
China |
Drug Development & Therapeutics,
Medical Devices
|
CNY 54
|
$8.2B |
13.7x |
45.6x |
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 34149
|
$8.1B |
10.7x |
39.6x |
Haisco Pharmaceutical
|
China |
Drug Development & Therapeutics
|
CNY 49
|
$7.8B |
13.4x |
75.4x |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$7.7B |
0.2x |
3.5x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$56
|
$7.7B |
6.8x |
10.6x |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1139
|
$7.7B |
2.0x |
9.7x |
Kelun
|
China |
Drug Development & Therapeutics,
Medical Supplies
|
CNY 35
|
$7.7B |
2.5x |
11.0x |
Kyowa Kirin
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2523
|
$7.6B |
2.3x |
9.8x |
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2223
|
$7.4B |
4.6x |
25.1x |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 131663
|
$7.2B |
4.6x |
66.5x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$71
|
$7.2B |
9.0x |
N/A |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3948
|
$7.2B |
1.3x |
10.6x |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$7.2B |
N/A |
N/A |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£20
|
$7.2B |
2.1x |
8.1x |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 33
|
$7.1B |
N/A |
N/A |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$42
|
$7.0B |
8.3x |
-47.0x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$27
|
$6.9B |
1.6x |
9.1x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$31
|
$6.9B |
2.6x |
-1.8x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$334
|
$6.7B |
14.7x |
-15.4x |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 4999
|
$6.6B |
4.2x |
21.8x |
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 31
|
$6.5B |
1.5x |
8.2x |
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€199
|
$6.3B |
2.8x |
10.0x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 3144
|
$5.9B |
13.2x |
41.7x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$42
|
$5.9B |
8.1x |
-12.8x |
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$5.9B |
12.6x |
53.1x |